Stocks and InvestingStocks and Investing
Wed, May 31, 2023
Tue, May 30, 2023
Mon, May 29, 2023
Sun, May 28, 2023
Fri, May 26, 2023

Hartaj Singh Reiterated (SRPT) at Buy and Held Target at $180 on, May 26th, 2023


Published on 2024-10-28 04:04:16 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Reiterated "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $180 on, May 26th, 2023.

Hartaj has made no other calls on SRPT in the last 4 months.



There are 15 other peers that have a rating on SRPT. Out of the 15 peers that are also analyzing SRPT, 1 agrees with Hartaj's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Judah Frommer of "Credit Suisse" Maintained at Hold with Increased Target to $151 on, Monday, May 15th, 2023


These are the ratings of the 14 analyists that currently disagree with Hartaj


  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $185 on, Wednesday, May 24th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $218 on, Tuesday, May 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $173 on, Monday, May 15th, 2023
  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $173 on, Monday, May 15th, 2023
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $176 on, Monday, May 15th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $158 on, Wednesday, May 3rd, 2023
  • David Hoang of "SMBC Nikko" Initiated at Buy and Held Target at $185 on, Wednesday, April 26th, 2023
  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Friday, April 14th, 2023
  • Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $179 on, Tuesday, April 4th, 2023
  • Ritu Baral of "TD Cowen" Maintained at Buy with Increased Target to $175 on, Wednesday, March 22nd, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $206 on, Friday, March 3rd, 2023
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, March 1st, 2023
  • Brian Skorney of "Baird" Maintained at Buy with Increased Target to $202 on, Wednesday, March 1st, 2023
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $187 on, Wednesday, March 1st, 2023